Literature DB >> 21842119

Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells.

Yoshie Yoshikawa1, Ayuko Sato, Tohru Tsujimura, Tomonori Morinaga, Kazuya Fukuoka, Shusai Yamada, Aki Murakami, Nobuyuki Kondo, Seiji Matsumoto, Yoshitomo Okumura, Fumihiro Tanaka, Seiki Hasegawa, Tomoko Hashimoto-Tamaoki, Takashi Nakano.   

Abstract

Array-based comparative genomic hybridization analysis was performed on 21 malignant mesothelioma (MM) samples (16 primary cell cultures and 5 cell lines) and two reactive mesothelial hyperplasia (RM) primary cell cultures. The RM samples did not have any genomic losses or gains. In MM samples, deletions in 1p, 3p21, 4q, 9p21, 16p13 and 22q were detected frequently. We focused on 3p21 because this deletion was specific to the epithelioid type. Especially, a deletion in 3p21.1 region carrying seven genes including SEMA3G was found in 52% of MM samples (11 of 14 epithelioid samples). The allele loss of 3p21.1 might be a good marker for the epithelioid MM. A homozygous deletion in this region was detected in two MM primary cell cultures. A heterozygous deletion detected in nine samples contained the 3p21.1 region and 3p21.31 one carrying the candidate tumor suppressor genes such as semaphorin 3F (SEMA3F), SEMA3B and Ras association (RalGDS/AF-6) domain family member 1 (RASSF1A). SEMA3B, 3F and 3G are class 3 semaphorins and inhibit growth by competing with vascular endothelial growth factor (VEGF) through binding to neuropilin. All MM samples downregulated the expression of more than one gene for SEMA3B, 3F and 3G when compared with Met5a, a normal pleura-derived cell line. Moreover, in 12 of 14 epithelioid MM samples the expression level of SEMA3A was lower than that in Met5a and the two RM samples. An augmented expression of VEGFA was detected in half of the MM samples. The expression ratio of VEGFA/SEMA3A was significantly higher in the epithelioid MMs than in Met5a, RMs and the non-epithelioid MMs. Our data suggest that the downregulated expression of SEMA3A and several SEMA3s results in a loss of inhibitory activities in tumor angiogenesis and tumor growth of VEGFA; therefore, it may play an important role on the pathogenesis of the epithelioid type of MM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21842119     DOI: 10.3892/ijo.2011.1158

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  12 in total

1.  Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.

Authors:  Gian Paolo Dagrada; Silvana Pilotti; Silvia Brich; Fabio Bozzi; Federica Perrone; Elena Tamborini; Antonello Domenico Cabras; Marcello Deraco; Silvia Stacchiotti
Journal:  Mod Pathol       Date:  2019-09-30       Impact factor: 7.842

2.  Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines.

Authors:  Geula Klorin; Ester Rozenblum; Oleg Glebov; Robert L Walker; Yoonsoo Park; Paul S Meltzer; Ilan R Kirsch; Frederic J Kaye; Anna V Roschke
Journal:  Cancer Genet       Date:  2013-07-05

3.  BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.

Authors:  Marta Cigognetti; Silvia Lonardi; Simona Fisogni; Piera Balzarini; Vilma Pellegrini; Andrea Tironi; Luisa Bercich; Mattia Bugatti; Giulio Rossi; Bruno Murer; Mattia Barbareschi; Silvia Giuliani; Alberto Cavazza; Gianpietro Marchetti; William Vermi; Fabio Facchetti
Journal:  Mod Pathol       Date:  2015-05-29       Impact factor: 7.842

4.  High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma.

Authors:  Yoshie Yoshikawa; Mitsuru Emi; Tomoko Hashimoto-Tamaoki; Masaki Ohmuraya; Ayuko Sato; Tohru Tsujimura; Seiki Hasegawa; Takashi Nakano; Masaki Nasu; Sandra Pastorino; Agata Szymiczek; Angela Bononi; Mika Tanji; Ian Pagano; Giovanni Gaudino; Andrea Napolitano; Chandra Goparaju; Harvey I Pass; Haining Yang; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-09       Impact factor: 11.205

Review 5.  Pathological and molecular biological approaches to early mesothelioma.

Authors:  Tohru Tsujimura; Ikuko Torii; Ayuko Sato; Misa Song; Kazuya Fukuoka; Seiki Hasegawa; Takashi Nakano
Journal:  Int J Clin Oncol       Date:  2012-01-12       Impact factor: 3.402

Review 6.  Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy.

Authors:  Seiki Hasegawa; Nobuyuki Kondo; Seiji Matsumoto; Teruhisa Takuwa; Masaki Hashimoto; Hayato Orui; Shunichi Fukuda; Kazue Yoneda; Yoshitomo Okumura; Noriaki Tsubota; Kazuya Fukuoka; Ikuko Torii; Tohru Tsujimura; Takashi Nakano
Journal:  Int J Clin Oncol       Date:  2012-01-12       Impact factor: 3.402

7.  Endothelium-derived semaphorin 3G attenuates ischemic retinopathy by coordinating β-catenin-dependent vascular remodeling.

Authors:  Dan-Yang Chen; Ning-He Sun; Xiang Chen; Jun-Jie Gong; Song-Tao Yuan; Zi-Zhong Hu; Nan-Nan Lu; Jakob Körbelin; Kohji Fukunaga; Qing-Huai Liu; Ying-Mei Lu; Feng Han
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

8.  Molecular characterization of pleomorphic mesothelioma: a multi-institutional study.

Authors:  Somak Roy; Françoise Galateau-Sallé; Nolwenn Le Stang; Andrew Churg; Maureen A Lyons; Richard Attanoos; Sanja Dacic
Journal:  Mod Pathol       Date:  2021-09-16       Impact factor: 7.842

9.  Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection.

Authors:  Zhi-Qiang Hu; Shao-Lai Zhou; Zheng-Jun Zhou; Chu-Bin Luo; Er-Bao Chen; Hao Zhan; Peng-Cheng Wang; Zhi Dai; Jian Zhou; Jia Fan; Xiao-Wu Huang
Journal:  Oncotarget       Date:  2016-08-09

Review 10.  The emerging role of class-3 semaphorins and their neuropilin receptors in oncology.

Authors:  Patrick Nasarre; Robert M Gemmill; Harry A Drabkin
Journal:  Onco Targets Ther       Date:  2014-09-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.